Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of General Internal Medicine|December 22, 2023
Patient Portal Message Volume and Time Spent on the EHR: an Observational Study of Primary Care CliniciansKathryn A Martinez, Rebecca Schulte, Michael B Rothberg, et al.
Digestive Diseases and Sciences|January 16, 2022
Helicobacter pylori Management Is Associated with Predominantly Negative Patient Experiences: Results from a Focused Qualitative AnalysisShailja C Shah, Kemberlee Bonnet, Rebecca Schulte, et al.
JAMA Network Open|September 13, 2024
One-Year Weight Reduction With Semaglutide or Liraglutide in Clinical PracticeHamlet Gasoyan, Elizabeth R Pfoh, Rebecca Schulte, et al.
Medrxiv : the Preprint Server for Health Sciences|September 10, 2024
What Constitutes High Risk for Venous Thromboembolism? Comparing Approaches to Determining an Appropriate ThresholdBenjamin G Mittman, Bo Hu, Rebecca Schulte, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|October 25, 2024
Acceptance of pharmacist-led stewardship recommendations for patients with community-acquired pneumoniaRamara E Walker, Rebecca Schulte, Andrea M Pallotta, et al.
Journal of General Internal Medicine|March 30, 2023
Relationship Between Oral Temperature and Bacteremia in Hospitalized PatientsSidra L Speaker, Elizabeth R Pfoh, Matthew A Pappas, et al.
Trials|September 16, 2023
Reducing antimicrobial overuse through targeted therapy for patients with community-acquired pneumonia: a study protocol for a cluster-randomized factorial controlled trial (CARE-CAP)Abhishek Deshpande, Ramara Walker, Rebecca Schulte, et al.
Women'S Health Issues : Official Publication of the Jacobs Institute of Women'S Health|June 6, 2021
Reproductive-Age Women's Experience of Accessing Treatment for Opioid Use Disorder: "We Don't Do That Here"Julia C Phillippi, Rebecca Schulte, Kemberlee Bonnet, et al.
Obesity (Silver Spring, Md.)|June 10, 2025
Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation statusHamlet Gasoyan, W Scott Butsch, Rebecca Schulte, et al.
Obesity (Silver Spring, Md.)|October 3, 2025
Reasons for Discontinuation of Obesity Pharmacotherapy With Semaglutide or Tirzepatide in Clinical PracticeHamlet Gasoyan, W Scott Butsch, Nicholas J Casacchia, et al.
Pageof 3